| Plegridy (PEG-interferon β-1a) / Biogen |
NCT02125578: A Multiple Dose Safety Study of PEG-IFN in Healthy Volunteers |
|
|
| Completed | 1 | 69 | US | BIIB017 (PEGylated Interferon Beta-1a), Placebo | Biogen | Healthy | 05/08 | 05/08 | | |
NCT01119781: A Single-Dose, Pharmacokinetic/Pharmacodynamic (PK/PD), & Safety Study of BIIB017 in Participants With Renal Impairment & Healthy Volunteers |
|
|
| Completed | 1 | 35 | US | BIIB017(peginterferon beta-1a) | Biogen | Healthy, Renal Insufficiency | 08/11 | 08/11 | | |
NCT01610310: Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers |
|
|
| Completed | 1 | 55 | US | BIIB017 (peginterferon beta-1a) Pre-filled syringe (PFS), BIIB017, BIIB017 (peginterferon beta-1a) Autoinjector | Biogen | Healthy, Multiple Sclerosis | 10/12 | 10/12 | | |
NCT01978652: Pharmacokinetic Study of Peginterferon Beta-1a in Japanese and Caucasian Adult Healthy Participants. |
|
|
| Completed | 1 | 44 | Europe | Peginterferon Beta-1a, Plegridy, BIIB017 | Biogen | Healthy | 02/14 | 02/14 | | |
NCT02269930: Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers |
|
|
| Completed | 1 | 30 | US | peginterferon beta-1a, BIIB017, Plegridy, Rebif | Biogen | Multiple Sclerosis | 12/14 | 12/14 | | |
